Patents by Inventor Prabha MISHRA

Prabha MISHRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical combination for the treatment of cancer
    Patent number: 11925618
    Abstract: The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: March 12, 2024
    Assignee: Piramal Enterprises Limited
    Inventors: Owe Orwar, Sreesha Srinivasa, Prabha Mishra
  • Pharmaceutical Combination for the Treatment of Cancer
    Publication number: 20220168273
    Abstract: The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
    Type: Application
    Filed: December 13, 2021
    Publication date: June 2, 2022
    Applicant: Piramal Enterprises Limited
    Inventors: Owe Orwar, Sreesha Srinivasa, Prabha Mishra
  • Pharmaceutical combination for the treatment of cancer
    Patent number: 11234963
    Abstract: The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: February 1, 2022
    Assignee: Piramal Enterprises Limited
    Inventors: Owe Orwar, Sreesha Srinivasa, Prabha Mishra
  • PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
    Publication number: 20200138782
    Abstract: The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
    Type: Application
    Filed: December 23, 2019
    Publication date: May 7, 2020
    Applicant: Piramal Enterprises Limited
    Inventors: Owe ORWAR, Sreesha SRINIVASA, Prabha MISHRA
  • Pharmaceutical combination for the treatment of cancer
    Patent number: 10555931
    Abstract: The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: February 11, 2020
    Assignee: PIRAMAL ENTERPRISES LIMITED
    Inventors: Owe Orwar, Sreesha Srinivasa, Prabha Mishra
  • PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
    Publication number: 20170112809
    Abstract: The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
    Type: Application
    Filed: May 27, 2015
    Publication date: April 27, 2017
    Applicant: Piramal Enterprises Limited
    Inventors: Owe ORWAR, Sreesha SRINIVASA, Prabha MISHRA